SCHEMBL8778660

SCHEMBL8778660

Cc1ccc(-c2ncc3ccccc3n2)nc1Sc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.42
ALDH1A1 P00352 7/20 0.42
SMN1; SMN2 Q16637 6/20 0.42
L3MBTL1 Q9Y468 5/20 0.42
PPP1CA P62136 5/20 0.42
MEN1 O00255 5/20 0.42
KMT2A Q03164 5/20 0.42
ABCG2 Q9UNQ0 1/20 0.41
HTT P42858 4/20 0.41
HPGD P15428 2/20 0.41
CYP1A2 P05177 3/20 0.40
KDM4E B2RXH2 2/20 0.38
GAA P10253 2/20 0.38
LMNA P02545 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HRH4 Q9H3N8 1/20 0.36
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8778644 0.83 MAPT (0.47) MAPTALDH1A1SMN1; SMN2L3MBTL1PPP1CA
SCHEMBL8778596 0.79 HPGD (0.47) MAPTALDH1A1SMN1; SMN2L3MBTL1PPP1CA
SCHEMBL8778671 0.78 CYP1A2 (0.46) ALDH1A1HPGDCYP1A2KDM4EGAA
SCHEMBL8776938 0.76 PDE10A (0.51) MAPTALDH1A1SMN1; SMN2L3MBTL1MEN1
SCHEMBL8515341 0.76 TDP1 (0.49) CYP1A2KDM4ENPC1TDP1HRH4
SCHEMBL8766869 0.75 CYP1A2 (0.39) ALDH1A1SMN1; SMN2MEN1KMT2AHPGD
SCHEMBL8778654 0.75 SMN1; SMN2 (0.52) MAPTALDH1A1SMN1; SMN2L3MBTL1PPP1CA
SCHEMBL8777140 0.74 CYP1A2 (0.50) MAPTALDH1A1SMN1; SMN2MEN1KMT2A
SCHEMBL8778658 0.74 CYP1A2 (0.40) MAPTALDH1A1SMN1; SMN2L3MBTL1PPP1CA
SCHEMBL8870416 0.73 CYP1A2 (0.42) MEN1KMT2ACYP1A2KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120129875-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES SYNGENTA CROP PROTECTION, LLC (US) 2012-05-24 US disclosed
US-20120129875-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES SYNGENTA CROP PROTECTION, LLC (US) 2012-05-24 US disclosed
WO-2010136475-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES SYNGENTA PARTICIPATIONS AG (CH) 2010-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120129875-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES NAT1, NQO2, NOX1 MAPT 3067/4885ALDH1A1 1125/4885SMN1; SMN2 3646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.